NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

粘膜藥物輸送設備:醫療設備的開發中產品情勢 (2021年)

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021

出版商 GlobalData 商品編碼 1023537
出版日期 內容資訊 英文 210 Pages
訂單完成後即時交付
價格
粘膜藥物輸送設備:醫療設備的開發中產品情勢 (2021年) Transmucosal Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021
出版日期: 2021年08月13日內容資訊: 英文 210 Pages
簡介

本報告提供全球粘膜藥物輸送設備市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,並彙整產品特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (資本交易、事業聯盟等) 等資訊,為您概述為以下內容。

目錄

第1章 目錄

第2章 簡介

  • 粘膜藥物輸送概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 在粘膜藥物輸送:各企業現在臨床實驗中的開發中產品

  • 粘膜藥物輸送的企業:各臨床實驗階段的開發中產品
  • 粘膜藥物輸送:各臨床實驗階段的開發中產品

第5章 粘膜藥物輸送:企業、產品概要

  • AcelRx Pharmaceuticals Inc
  • AFYX Therapeutics A/S
  • Albert Einstein College of Medicine
  • Allergan Ltd
  • Altamira Medica AG
  • Amphastar Pharmaceuticals Inc
  • Anelleo Inc
  • APR Applied Pharma Research SA
  • ARS Pharmaceuticals Inc
  • Auris Medical AG
  • Auritec Pharmaceuticals Inc
  • Bayer Healthcare LLC
  • BeFree!
  • Bespak Europe Ltd
  • Biorings LLC
  • BioXcel Therapeutics Inc
  • Bryn Pharma LLC
  • Callitas Therapeutics Inc
  • Combinent BioMedical Systems Inc
  • Conrad
  • Dare Bioscience Inc
  • Eledon Pharmaceuticals Inc
  • Emergent BioSolutions Inc
  • Ena Respiratory Pty Ltd
  • Eureka Therapeutics Inc
  • Evestra Inc
  • EyeGate Pharmaceuticals Inc
  • Ferring Pharmaceuticals AS
  • Ghent University
  • Glenmark Pharmaceuticals Ltd
  • Grunenthal Ltd
  • Hebrew University of Jerusalem
  • Hikma Pharmaceuticals Plc
  • Insys Therapeutics Inc (Inactive)
  • IntelGenx Corp
  • ITF Pharma Inc
  • Janssen Sciences Ireland UC
  • Karessa Pharma AB
  • Kytogenics Pharmaceuticals Inc
  • Laboratoire HRA Pharma SAS
  • Laboratorios Andromaco
  • Lyra Therapeutics Inc
  • McNeil AB
  • Medlab Clinical Ltd
  • Merck & Co Inc
  • Merck Serono SA
  • Merck Sharp & Dohme Ltd
  • Mithra Pharmaceuticals SA
  • Mucommune LLC
  • Mystic Pharmaceuticals Inc
  • Nanosys Inc
  • Nasus Pharma Ltd
  • Nemera La Verpilliere
  • NorInvent AB
  • Opiant Pharmaceuticals Inc
  • OptiNose AS
  • OptiNose Inc
  • Orion Biotechnology Canada Ltd
  • Orphanse Healthcare SAS
  • Oyster Point Pharma Inc
  • Palette Life Sciences AB
  • Phoenix Life Sciences International Ltd
  • RDD Pharma Ltd (Inactive)
  • Renown Pharmaceuticals Pvt Ltd
  • Rhinomed Limited
  • Scientus Pharma Inc
  • Seelos Therapeutics, Inc.
  • Shin Nippon Biomedical Laboratories Ltd
  • SipNose Ltd
  • Starpharma Holdings Ltd
  • Suda Pharmaceuticals Ltd
  • Therakind Ltd
  • University of Pittsburgh
  • University of South Florida
  • University of Texas at Austin
  • University of the Witwatersrand
  • University of Washington
  • VistaGen Therapeutics Inc
  • Washington University in St Louis
  • Xlear Inc
  • Zosano Pharma Corp
  • Zydus Healthcare Ltd

第6章 粘膜藥物輸送:近來的市場趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1146EPD

GlobalData's Medical Devices sector report, "Transmucosal Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Transmucosal Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transmucosal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transmucosal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transmucosal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Transmucosal Drug Delivery Overview

3 Products under Development

  • 3.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • 3.2 Transmucosal Drug Delivery - Pipeline Products by Segment
  • 3.3 Transmucosal Drug Delivery - Pipeline Products by Territory
  • 3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
  • 3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
  • 3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials

4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies

  • 4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development

5 Transmucosal Drug Delivery Companies and Product Overview

  • 5.1 AcelRx Pharmaceuticals Inc Company Overview
  • 5.2 AFYX Therapeutics A/S Company Overview
  • 5.3 Albert Einstein College of Medicine Company Overview
  • 5.4 Allergan Ltd Company Overview
  • 5.5 Altamira Medica AG Company Overview
  • 5.6 Amphastar Pharmaceuticals Inc Company Overview
  • 5.7 Anelleo Inc Company Overview
  • 5.8 APR Applied Pharma Research SA Company Overview
  • 5.9 ARS Pharmaceuticals Inc Company Overview
  • 5.10 Auris Medical AG Company Overview
  • 5.11 Auritec Pharmaceuticals Inc Company Overview
  • 5.12 Bayer Healthcare LLC Company Overview
  • 5.13 BeFree! Company Overview
  • 5.14 Bespak Europe Ltd Company Overview
  • 5.15 Biorings LLC Company Overview
  • 5.16 BioXcel Therapeutics Inc Company Overview
  • 5.17 Bryn Pharma LLC Company Overview
  • 5.18 Callitas Therapeutics Inc Company Overview
  • 5.19 Combinent BioMedical Systems Inc Company Overview
  • 5.20 Conrad Company Overview
  • 5.21 Dare Bioscience Inc Company Overview
  • 5.22 Eledon Pharmaceuticals Inc Company Overview
  • 5.23 Emergent BioSolutions Inc Company Overview
  • 5.24 Ena Respiratory Pty Ltd Company Overview
  • 5.25 Eureka Therapeutics Inc Company Overview
  • 5.26 Evestra Inc Company Overview
  • 5.27 EyeGate Pharmaceuticals Inc Company Overview
  • 5.28 Ferring Pharmaceuticals AS Company Overview
  • 5.29 Ghent University Company Overview
  • 5.30 Glenmark Pharmaceuticals Ltd Company Overview
  • 5.31 Grunenthal Ltd Company Overview
  • 5.32 Hebrew University of Jerusalem Company Overview
  • 5.33 Hikma Pharmaceuticals Plc Company Overview
  • 5.34 Insys Therapeutics Inc (Inactive) Company Overview
  • 5.35 IntelGenx Corp Company Overview
  • 5.36 ITF Pharma Inc Company Overview
  • 5.37 Janssen Sciences Ireland UC Company Overview
  • 5.38 Karessa Pharma AB Company Overview
  • 5.39 Kytogenics Pharmaceuticals Inc Company Overview
  • 5.40 Laboratoire HRA Pharma SAS Company Overview
  • 5.41 Laboratorios Andromaco Company Overview
  • 5.42 Lyra Therapeutics Inc Company Overview
  • 5.43 McNeil AB Company Overview
  • 5.44 Medlab Clinical Ltd Company Overview
  • 5.45 Merck & Co Inc Company Overview
  • 5.46 Merck Serono SA Company Overview
  • 5.47 Merck Sharp & Dohme Ltd Company Overview
  • 5.48 Mithra Pharmaceuticals SA Company Overview
  • 5.49 Mucommune LLC Company Overview
  • 5.50 Mystic Pharmaceuticals Inc Company Overview
  • 5.51 Nanosys Inc Company Overview
  • 5.52 Nasus Pharma Ltd Company Overview
  • 5.53 Nemera La Verpilliere Company Overview
  • 5.54 NorInvent AB Company Overview
  • 5.55 Opiant Pharmaceuticals Inc Company Overview
  • 5.56 OptiNose AS Company Overview
  • 5.57 OptiNose Inc Company Overview
  • 5.58 Orion Biotechnology Canada Ltd Company Overview
  • 5.59 Orphanse Healthcare SAS Company Overview
  • 5.60 Oyster Point Pharma Inc Company Overview
  • 5.61 Palette Life Sciences AB Company Overview
  • 5.62 Phoenix Life Sciences International Ltd Company Overview
  • 5.63 RDD Pharma Ltd (Inactive) Company Overview
  • 5.64 Renown Pharmaceuticals Pvt Ltd Company Overview
  • 5.65 Rhinomed Limited Company Overview
  • 5.66 Scientus Pharma Inc Company Overview
  • 5.67 Seelos Therapeutics, Inc. Company Overview
  • 5.68 Shin Nippon Biomedical Laboratories Ltd Company Overview
  • 5.69 SipNose Ltd Company Overview
  • 5.70 Starpharma Holdings Ltd Company Overview
  • 5.71 Suda Pharmaceuticals Ltd Company Overview
  • 5.72 Therakind Ltd Company Overview
  • 5.73 University of Pittsburgh Company Overview
  • 5.74 University of South Florida Company Overview
  • 5.75 University of Texas at Austin Company Overview
  • 5.76 University of the Witwatersrand Company Overview
  • 5.77 University of Washington Company Overview
  • 5.78 VistaGen Therapeutics Inc Company Overview
  • 5.79 Washington University in St Louis Company Overview
  • 5.80 Xlear Inc Company Overview
  • 5.81 Zosano Pharma Corp Company Overview
  • 5.82 Zydus Healthcare Ltd Company Overview

6 Transmucosal Drug Delivery- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • Transmucosal Drug Delivery - Pipeline Products by Segment
  • Transmucosal Drug Delivery - Pipeline Products by Territory
  • Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
  • Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
  • Transmucosal Drug Delivery - Ongoing Clinical Trials
  • Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
  • Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • Transmucosal Drug Delivery - Pipeline Products by Segment
  • Transmucosal Drug Delivery - Pipeline Products by Territory
  • Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
  • Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
  • Transmucosal Drug Delivery - Ongoing Clinical Trials